Brind.
  1. Stereotaxis announced that David Fischel was appointed Chairman and CEO, and the company filed an offering pursuant to an SEC registration statement.

Stereotaxis, led by CEO David Fischel, participated in the MAGiC catheter study at Vilnius University Hospital on July 1, 2025.

1 report, 0 independent Updated Jul 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Stereotaxis, led by CEO David Fischel, participated in the MAGiC catheter study at Vilnius University Hospital on July 1, 2025.

Who's involved

What this event is mainly about
StereotaxisDavid Fischel

Keep exploring

Part of

Stereotaxis announced that David Fischel was appointed Chairman and CEO, and the company filed an offering pursuant to an SEC registration statement. All 1 developments

The entities involved

Coverage

Newest first; wire copies grouped
  • Unknown outlet